The meningitis drug pipeline is advancing with new antibiotics, vaccines, and biologics, driven by rising infection rates, antimicrobial resistance, and global vaccination initiatives. https://paperpage.in/blogs/456241/Meningitis-Drug-Pipeline-Analysis-Market-Demand-and-Forecast-2034